ONDANSETRON VERSUS GRANISETRON IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING

被引：0
|
作者：
FEDELE, P
SPINA, M
VALENTINI, M
COLLINI, D
LUCIA, C
MANICONE, M
TIRELLI, U
机构：
来源：
CANCER | 1995年 / 76卷 / 03期
关键词：
D O I：
10.1002/1097-0142(19950801)76:3<535::AID-CNCR2820760331>3.0.CO;2-K
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：535 / 536
页数：2
相关论文
共 50 条
  • [1] ONDANSETRON VERSUS GRANISETRON IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING - REPLY
    GEBBIA, V
    CANNATA, G
    GEBBIA, N
    CANCER, 1995, 76 (03) : 536 - 536
  • [2] ONDANSETRON VERSUS GRANISETRON IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL
    GEBBIA, V
    CANNATA, G
    TESTA, A
    CURTO, G
    VALENZA, R
    CIPOLLA, C
    LATTERI, MA
    GEBBIA, N
    CANCER, 1994, 74 (07) : 1945 - 1952
  • [3] ONDANSETRON VERSUS METOCLOPRAMIDE IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING - A METAANALYSIS
    RUSTHOVEN, J
    OBRIEN, BJ
    ROCCHI, A
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1992, 1 (04) : 443 - 450
  • [4] Palonosetron versus ondansetron in CINV (chemotherapy-induced nausea and vomiting)
    Vieira, S.
    Monroe, D.
    Sorita, R.
    Palomar, M.
    Librojo, M.
    Porin, L.
    Ng, J.
    Taylor, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S370 - S370
  • [5] Efficacy and safety of oral granisetron vs IV ondansetron in prevention of moderately emetogenic chemotherapy-induced nausea and vomiting
    Perez, EA
    Chawla, SP
    Kaywin, PK
    Sandbach, J
    Yocom, K
    Preston, A
    Friedman, C
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 64 - 64
  • [6] Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)
    Lee Schwartzberg
    Sally Y. Barbour
    Gary R. Morrow
    Gianluca Ballinari
    Michael D. Thorn
    David Cox
    Supportive Care in Cancer, 2014, 22 : 469 - 477
  • [7] Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)
    Schwartzberg, Lee
    Barbour, Sally Y.
    Morrow, Gary R.
    Ballinari, Gianluca
    Thorn, Michael D.
    Cox, David
    SUPPORTIVE CARE IN CANCER, 2014, 22 (02) : 469 - 477
  • [8] Analysis of phase III clinical studies for palonosetron, ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV).
    Barbour, S. Y.
    Morrow, G. R.
    Ahmed, R.
    Ballinari, G.
    Thorn, M. D.
    Cox, D.
    Schwartzberg, L. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer
    Fujiwara, Satoe
    Terai, Yoshito
    Tsunetoh, Satoshi
    Sasaki, Hiroshi
    Kanemura, Masanori
    Ohmichi, Masahide
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2015, 26 (04) : 311 - 319
  • [10] Granisetron and ondansetron for chemotherapy-related nausea and vomiting
    Zeidman, A
    Ben Dayan, D
    Ben Zion, T
    Kaufman, O
    Cohen, AM
    Mittelman, M
    HAEMATOLOGIA, 1998, 29 (01) : 25 - 31
12345